IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-37049-z.html
   My bibliography  Save this article

ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma

Author

Listed:
  • Miwa Tanaka

    (Division of Carcinogenesis, The Cancer Institute, Japanese Foundation for Cancer Research
    Tokyo Medical University
    Project for Cancer Epigenomics, The Cancer Institute, Japanese Foundation for Cancer Research)

  • Surachada Chuaychob

    (Kyoto University)

  • Mizuki Homme

    (Division of Carcinogenesis, The Cancer Institute, Japanese Foundation for Cancer Research
    Division of Cell Biology, The Cancer Institute, Japanese Foundation for Cancer Research)

  • Yukari Yamazaki

    (Division of Carcinogenesis, The Cancer Institute, Japanese Foundation for Cancer Research
    Tokyo Medical University)

  • Ruyin Lyu

    (Kyoto University)

  • Kyoko Yamashita

    (Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research)

  • Keisuke Ae

    (Cancer Institute Hospital, Japanese Foundation for Cancer Research)

  • Seiichi Matsumoto

    (Cancer Institute Hospital, Japanese Foundation for Cancer Research)

  • Kohei Kumegawa

    (Project for Cancer Epigenomics, The Cancer Institute, Japanese Foundation for Cancer Research)

  • Reo Maruyama

    (Project for Cancer Epigenomics, The Cancer Institute, Japanese Foundation for Cancer Research)

  • Wei Qu

    (The University of Tokyo)

  • Yohei Miyagi

    (Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute)

  • Ryuji Yokokawa

    (Kyoto University)

  • Takuro Nakamura

    (Division of Carcinogenesis, The Cancer Institute, Japanese Foundation for Cancer Research
    Tokyo Medical University)

Abstract

Alveolar soft part sarcoma (ASPS) is a soft part malignancy affecting adolescents and young adults. ASPS is characterized by a highly integrated vascular network, and its high metastatic potential indicates the importance of ASPS’s prominent angiogenic activity. Here, we find that the expression of ASPSCR1::TFE3, the fusion transcription factor causatively associated with ASPS, is dispensable for in vitro tumor maintenance; however, it is required for in vivo tumor development via angiogenesis. ASPSCR1::TFE3 is frequently associated with super-enhancers (SEs) upon its DNA binding, and the loss of its expression induces SE-distribution dynamic modification related to genes belonging to the angiogenesis pathway. Using epigenomic CRISPR/dCas9 screening, we identify Pdgfb, Rab27a, Sytl2, and Vwf as critical targets associated with reduced enhancer activities due to the ASPSCR1::TFE3 loss. Upregulation of Rab27a and Sytl2 promotes angiogenic factor-trafficking to facilitate ASPS vascular network construction. ASPSCR1::TFE3 thus orchestrates higher ordered angiogenesis via modulating the SE activity.

Suggested Citation

  • Miwa Tanaka & Surachada Chuaychob & Mizuki Homme & Yukari Yamazaki & Ruyin Lyu & Kyoko Yamashita & Keisuke Ae & Seiichi Matsumoto & Kohei Kumegawa & Reo Maruyama & Wei Qu & Yohei Miyagi & Ryuji Yokoka, 2023. "ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37049-z
    DOI: 10.1038/s41467-023-37049-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-37049-z
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-37049-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Rene C. Adam & Hanseul Yang & Shira Rockowitz & Samantha B. Larsen & Maria Nikolova & Daniel S. Oristian & Lisa Polak & Meelis Kadaja & Amma Asare & Deyou Zheng & Elaine Fuchs, 2015. "Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice," Nature, Nature, vol. 521(7552), pages 366-370, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Pedro Madrigal & Siwei Deng & Yuliang Feng & Stefania Militi & Kim Jee Goh & Reshma Nibhani & Rodrigo Grandy & Anna Osnato & Daniel Ortmann & Stephanie Brown & Siim Pauklin, 2023. "Epigenetic and transcriptional regulations prime cell fate before division during human pluripotent stem cell differentiation," Nature Communications, Nature, vol. 14(1), pages 1-23, December.
    2. Mingsen Li & Huaxing Huang & Bofeng Wang & Shaoshuai Jiang & Huizhen Guo & Liqiong Zhu & Siqi Wu & Jiafeng Liu & Li Wang & Xihong Lan & Wang Zhang & Jin Zhu & Fuxi Li & Jieying Tan & Zhen Mao & Chunqi, 2022. "Comprehensive 3D epigenomic maps define limbal stem/progenitor cell function and identity," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    3. Andreas Lackner & Michael Müller & Magdalena Gamperl & Delyana Stoeva & Olivia Langmann & Henrieta Papuchova & Elisabeth Roitinger & Gerhard Dürnberger & Richard Imre & Karl Mechtler & Paulina A. Lato, 2023. "The Fgf/Erf/NCoR1/2 repressive axis controls trophoblast cell fate," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    4. Ines Sturmlechner & Chance C. Sine & Karthik B. Jeganathan & Cheng Zhang & Raul O. Fierro Velasco & Darren J. Baker & Hu Li & Jan M. Deursen, 2022. "Senescent cells limit p53 activity via multiple mechanisms to remain viable," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    5. Sandra Kessler & Maryline Minoux & Onkar Joshi & Yousra Zouari & Sebastien Ducret & Fiona Ross & Nathalie Vilain & Adwait Salvi & Joachim Wolff & Hubertus Kohler & Michael B. Stadler & Filippo M. Rijl, 2023. "A multiple super-enhancer region establishes inter-TAD interactions and controls Hoxa function in cranial neural crest," Nature Communications, Nature, vol. 14(1), pages 1-22, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37049-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.